glycine has been researched along with Neoplasm Metastasis in 23 studies
Neoplasm Metastasis: The transfer of a neoplasm from one organ or part of the body to another remote from the primary site.
| Excerpt | Relevance | Reference |
|---|---|---|
| "When three diazoacetyl-glycine derivatives, N-diazoacetyl-glycine amide (DGA), N-diazoacetyl-glycine hydrazide (DGI), and N-diazoacetyl-glycine ethyl ester (DGE), were tested against Lewis lung carcinoma in C57BL mice, DGA reduced sharply the number and weight of pulmonary metastases; the effects of DGI and DGE were less pronounced." | 3.65 | Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice. ( Giraldi, T; Nisi, C; Sava, G, 1977) |
| "Ixazomib is a selective and reversible inhibitor of the proteasome, which has been mainly investigated in the treatment of multiple myeloma." | 2.87 | Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial). ( Balic, M; Bartsch, R; Burgstaller, S; Egle, D; Fuchs, D; Gampenrieder, SP; Greil, R; Melchardt, T; Mlineritsch, B; Petru, E; Petzer, A; Rinnerthaler, G; Rossmann, D; Rumpold, H; Singer, CF; Ulmer, H, 2018) |
| "Using 36 biopsies from patients with brain tumors [12 glioblastoma multiforme (GBM); 10 low-grade (LG), including 7 schwannoma and 3 pylocytic astrocytoma; 7 meningioma (MN); 7 brain metastases (MT), including 3 adenocarcinoma and 4 breast cancer] and 9 control biopsies from patients undergoing surgery for epilepsy, we tested the hypothesis that the presence of glycine may distinguish among these brain tumor types." | 1.36 | High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors. ( Andronesi, OC; Black, PM; Mintzopoulos, D; Righi, V; Tzika, AA, 2010) |
| "Once positive the circulating tumor cells persisted in subsequent multiple blood samples." | 1.31 | K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells. ( Krygier, S; Luchtefeld, MA; Senagore, AJ; Thebo, JS, 2001) |
| "The putative metastasis suppressor genes, NME1(nm23-1) and NME2(nm23-2), were examined in a model system we developed to approximate the dissemination of melanoma from a primary skin tumor." | 1.29 | Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials. ( Backer, JM; Hamby, CV; Mendola, CE; Potla, L; Stafford, G, 1995) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 10 (43.48) | 18.7374 |
| 1990's | 4 (17.39) | 18.2507 |
| 2000's | 5 (21.74) | 29.6817 |
| 2010's | 4 (17.39) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Rinnerthaler, G | 1 |
| Gampenrieder, SP | 1 |
| Petzer, A | 1 |
| Burgstaller, S | 1 |
| Fuchs, D | 1 |
| Rossmann, D | 1 |
| Balic, M | 1 |
| Egle, D | 1 |
| Rumpold, H | 1 |
| Singer, CF | 1 |
| Bartsch, R | 1 |
| Petru, E | 1 |
| Melchardt, T | 1 |
| Ulmer, H | 1 |
| Mlineritsch, B | 1 |
| Greil, R | 1 |
| Muqaku, B | 1 |
| Eisinger, M | 1 |
| Meier, SM | 1 |
| Tahir, A | 1 |
| Pukrop, T | 1 |
| Haferkamp, S | 1 |
| Slany, A | 1 |
| Reichle, A | 1 |
| Gerner, C | 1 |
| Chatterjee, S | 1 |
| Mookerjee, A | 1 |
| Basu, JM | 1 |
| Chakraborty, P | 1 |
| Ganguly, A | 1 |
| Adhikary, A | 1 |
| Mukhopadhyay, D | 1 |
| Ganguly, S | 1 |
| Ganguli, S | 1 |
| Banerjee, R | 1 |
| Ashraf, M | 1 |
| Biswas, J | 1 |
| Das, PK | 1 |
| Sa, G | 1 |
| Chatterjee, M | 1 |
| Das, T | 1 |
| Choudhuri, SK | 1 |
| Righi, V | 1 |
| Andronesi, OC | 1 |
| Mintzopoulos, D | 1 |
| Black, PM | 1 |
| Tzika, AA | 1 |
| Rachagani, S | 1 |
| Senapati, S | 1 |
| Chakraborty, S | 1 |
| Ponnusamy, MP | 1 |
| Kumar, S | 1 |
| Smith, LM | 1 |
| Jain, M | 1 |
| Batra, SK | 1 |
| UNGER, RH | 1 |
| LOCHNERJDE, V | 1 |
| EISENTRAUT, AM | 1 |
| HORKY, J | 1 |
| PLACER, Z | 1 |
| Wang, J | 1 |
| Stockton, DW | 1 |
| Ittmann, M | 1 |
| Xiong, XB | 1 |
| Mahmud, A | 1 |
| Uludağ, H | 1 |
| Lavasanifar, A | 1 |
| Cardot-Bauters, C | 1 |
| Leteurtre, E | 1 |
| Leclerc, L | 1 |
| Vantyghem, MC | 1 |
| Do Cao, C | 1 |
| Wemeau, JL | 1 |
| d'Herbomez, M | 1 |
| Carnaille, B | 1 |
| Barbu, V | 1 |
| Pinson, S | 1 |
| Pigny, P | 1 |
| Hamby, CV | 1 |
| Mendola, CE | 1 |
| Potla, L | 1 |
| Stafford, G | 1 |
| Backer, JM | 1 |
| Pei, L | 1 |
| Melmed, S | 1 |
| Scheithauer, B | 1 |
| Kovacs, K | 1 |
| Prager, D | 1 |
| Lozonschi, L | 1 |
| Sunamura, M | 1 |
| Kobari, M | 1 |
| Egawa, S | 1 |
| Ding, L | 1 |
| Matsuno, S | 1 |
| Thebo, JS | 1 |
| Senagore, AJ | 1 |
| Krygier, S | 1 |
| Luchtefeld, MA | 1 |
| Giraldi, T | 2 |
| Guarino, AM | 1 |
| Nisi, C | 2 |
| Baldini, L | 1 |
| Sava, G | 1 |
| Guerinot, F | 1 |
| Bohuon, C | 1 |
| Saravis, CA | 1 |
| Oh, SK | 1 |
| Pusztaszeri, G | 1 |
| Doos, W | 1 |
| Zamcheck, N | 1 |
| Isoai, A | 1 |
| Ueno, Y | 1 |
| Giga-Hama, Y | 1 |
| Goto, H | 1 |
| Kumagai, H | 1 |
| Ward, HC | 1 |
| Johnson, AW | 1 |
| Halliday, D | 1 |
| Sim, AJ | 1 |
| Yancey, ST | 1 |
| Laki, K | 1 |
| Brunner, G | 1 |
| Sommer, J | 1 |
| Kattermann, R | 1 |
| Weise, HJ | 1 |
| Wiegandt, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Ixazomib (MLN9708) in Combination With Carboplatin in Pretreated Women With Advanced Triple Negative Breast Cancer[NCT02993094] | Phase 1/Phase 2 | 31 participants (Actual) | Interventional | 2016-11-21 | Terminated (stopped due to Due to slow recruitment, the study had to be terminated prematurely.) | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 trial available for glycine and Neoplasm Metastasis
| Article | Year |
|---|---|
Ixazomib in combination with carboplatin in pretreated women with advanced triple-negative breast cancer, a phase I/II trial of the AGMT (AGMT MBC-10 trial).
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Austria; Boron Compounds; Bortezomib; C | 2018 |
22 other studies available for glycine and Neoplasm Metastasis
| Article | Year |
|---|---|
Multi-omics Analysis of Serum Samples Demonstrates Reprogramming of Organ Functions Via Systemic Calcium Mobilization and Platelet Activation in Metastatic Melanoma.
Topics: Asparagine; Biomarkers, Tumor; Blood Platelets; Cachexia; Calcium; Glycine; Humans; Melanoma; Metabo | 2017 |
A novel copper chelate modulates tumor associated macrophages to promote anti-tumor response of T cells.
Topics: Animals; CD4-Positive T-Lymphocytes; Chelating Agents; Copper; Drug Resistance, Neoplasm; Glycine; I | 2009 |
High-resolution magic angle spinning magnetic resonance spectroscopy detects glycine as a biomarker in brain tumors.
Topics: Adolescent; Adult; Biomarkers, Tumor; Brain Neoplasms; Glioblastoma; Glycine; Humans; Inositol; Magn | 2010 |
Activated KrasG¹²D is associated with invasion and metastasis of pancreatic cancer cells through inhibition of E-cadherin.
Topics: Adenocarcinoma; Amino Acid Substitution; Animals; Aspartic Acid; Cadherins; Down-Regulation; Gene Ex | 2011 |
IDENTIFICATION OF INSULIN AND GLUGACON IN A BRONCHOGENIC METASTASIS.
Topics: Carcinoma; Carcinoma, Bronchogenic; Chemical Phenomena; Chemistry; Cysteine; Electrophoresis; Glucag | 1964 |
[DIAGNOSTIC SIGNIFICANCE OF SERUM PEPTIDASE DETERMINATION IN BLASTOMATOUS DISEASES].
Topics: Blood; Clinical Enzyme Tests; Diagnosis, Differential; Endopeptidases; Glycine; Heart Failure; Human | 1965 |
The fibroblast growth factor receptor-4 Arg388 allele is associated with prostate cancer initiation and progression.
Topics: Alleles; Arginine; Case-Control Studies; Cell Movement; Collagen; Disease Progression; DNA; DNA, Com | 2004 |
Conjugation of arginine-glycine-aspartic acid peptides to poly(ethylene oxide)-b-poly(epsilon-caprolactone) micelles for enhanced intracellular drug delivery to metastatic tumor cells.
Topics: Aldehydes; Arginine; Aspartic Acid; Cell Line, Tumor; Drug Delivery Systems; Glycine; Humans; Lacton | 2007 |
Does the RET variant G691S influence the features of sporadic medullary thyroid carcinoma?
Topics: Adolescent; Adult; Age of Onset; Aged; Carcinoma, Medullary; Case-Control Studies; Female; Genetic V | 2008 |
Differential expression and mutation of NME genes in autologous cultured human melanoma cells with different metastatic potentials.
Topics: Amino Acid Sequence; Animals; Base Sequence; Cell Line; Clone Cells; DNA Primers; Gene Expression; G | 1995 |
H-ras mutations in human pituitary carcinoma metastases.
Topics: Adenoma; Alanine; Arginine; Base Sequence; DNA, Neoplasm; Exons; Genes, p53; Genes, ras; Glycine; Hu | 1994 |
Controlling tumor angiogenesis and metastasis of C26 murine colon adenocarcinoma by a new matrix metalloproteinase inhibitor, KB-R7785, in two tumor models.
Topics: Adenocarcinoma; Animals; Colonic Neoplasms; Glycine; Hydroxamic Acids; Lung Neoplasms; Male; Metallo | 1999 |
K-ras mutational analysis of polyclonal colorectal cancers identifies uniclonal circulating tumor cells.
Topics: Aspartic Acid; Colorectal Neoplasms; Disease Progression; DNA Mutational Analysis; Genes, ras; Glyci | 2001 |
Selective antimetastatic effects of N-diazoacetylglycine derivatives in mice.
Topics: Animals; Azo Compounds; Drug Evaluation, Preclinical; Glycine; Lung Neoplasms; Mice; Neoplasm Metast | 1979 |
Antimetastatic effects of N-diazoacetyl-glycine derivatives in C57BL mice.
Topics: Animals; Azo Compounds; Glycine; Lung Neoplasms; Mice; Mice, Inbred C57BL; Neoplasm Metastasis; Neop | 1977 |
Glycine-N-methyltransferase levels in human breast cancer tissue.
Topics: Breast Neoplasms; Female; Glycine; Humans; Methyltransferases; Neoplasm Metastasis | 1977 |
Present status of the zinc glycinate marker (ZGM).
Topics: Antigens, Neoplasm; Chromatography, Gel; Colonic Neoplasms; Glycine; Humans; Neoplasm Metastasis; Ne | 1978 |
A novel Arg-Gly-Asp containing peptide specific for platelet aggregation and its effect on tumor metastasis: a possible mechanism of RGD peptide-mediated inhibition of tumor metastasis.
Topics: Animals; Anticarcinogenic Agents; Arginine; Aspartic Acid; Carcinoma, Squamous Cell; Cell Adhesion; | 1992 |
Elevated rates of whole body protein metabolism in patients with disseminated malignancy in the immediate postoperative period.
Topics: Aged; Female; Glycine; Humans; Male; Middle Aged; Neoplasm Metastasis; Nitrogen; Nitrogen Isotopes; | 1985 |
Transglutaminase and tumor growth.
Topics: Animals; Blood Coagulation; Cross Reactions; Dipeptides; Glutamine; Glycine; Glycosides; Guinea Pigs | 1972 |
[On the behavior of the so-called leucine aminopeptidase (LAP) in the serum during the application of various substrates].
Topics: Adolescent; Adult; Aged; Animals; Aspartate Aminotransferases; Biliary Tract Diseases; Cholestasis; | 1968 |
[On a rare form of metastasizing carcinoids in association with excessive isolated glycinuria].
Topics: Amino Acid Metabolism, Inborn Errors; Biopsy; Carcinoid Tumor; Female; Glycine; Humans; Iron; Liver | 1963 |